PSMA- versus FAP-RLT: Comparison of efficacy and post-treatment target expression in a double-positive mouse model of prostate cancer

Marco Taddio; Firas Hikmat; Zuo Chunlai; Tamara Lotan; Colm Morissey; Giuseppe Carlucci; Huihui Ye; Caius Radu; Katharina Lueckerath; Johannes Czernin; Christine Mona

Meeting ReportIn vitro and In vivo Oncology

PSMA- versus FAP-RLT: Comparison of efficacy and post-treatment target expression in a double-positive mouse model of prostate cancer

Marco Taddio, Firas Hikmat, Zuo Chunlai, Tamara Lotan, Colm Morissey, Giuseppe Carlucci, Huihui Ye, Caius Radu, Katharina Lueckerath, Johannes Czernin and Christine Mona

Journal of Nuclear Medicine August 2022, 63 (supplement 2) 4055;

Marco Taddio

1Ahmanson Translational Theranostics Division, Pharmacology, University of California, Los Angeles

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Firas Hikmat

2Ahmanson Translational Theranostics Division, Pharmacology, University of California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Zuo Chunlai

3Department of Pathology and Laboratory Medicine, University of California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tamara Lotan

4Johns Hopkins Hospital

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Colm Morissey

5Department of Urology, Washington University

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Giuseppe Carlucci

2Ahmanson Translational Theranostics Division, Pharmacology, University of California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Huihui Ye

6UCLA David Geffen School of Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Caius Radu

2Ahmanson Translational Theranostics Division, Pharmacology, University of California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Katharina Lueckerath

7University Hospital Essen, Nuclear Medicine

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Johannes Czernin

2Ahmanson Translational Theranostics Division, Pharmacology, University of California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christine Mona

2Ahmanson Translational Theranostics Division, Pharmacology, University of California

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 63, Issue supplement 2

August 1, 2022

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PSMA- versus FAP-RLT: Comparison of efficacy and post-treatment target expression in a double-positive mouse model of prostate cancer

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

PSMA- versus FAP-RLT: Comparison of efficacy and post-treatment target expression in a double-positive mouse model of prostate cancer

Marco Taddio, Firas Hikmat, Zuo Chunlai, Tamara Lotan, Colm Morissey, Giuseppe Carlucci, Huihui Ye, Caius Radu, Katharina Lueckerath, Johannes Czernin, Christine Mona

Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 4055;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

PSMA- versus FAP-RLT: Comparison of efficacy and post-treatment target expression in a double-positive mouse model of prostate cancer

Marco Taddio, Firas Hikmat, Zuo Chunlai, Tamara Lotan, Colm Morissey, Giuseppe Carlucci, Huihui Ye, Caius Radu, Katharina Lueckerath, Johannes Czernin, Christine Mona

Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 4055;

Share This Article: